This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A Phase 4 Study to Assess the Impact of Patient Su...
Clinical trial

A Phase 4 Study to Assess the Impact of Patient Support Program on Health Related Quality of Life and Adherence in Subjects With Relapsing-Remitting Multiple Sclerosis Administered Rebif� With the RebiSmart� Device (RebiQoL)

Read time: 1 mins
Last updated:12th Feb 2013
This is a randomized, comparative, and multicenter study to assess the impact of a patient support program (MinSupport Plus) on health related quality of life (HRQoL) and adherence in subjects with relapsing-remitting multiple sclerosis administered Rebif� with the RebiSmart� device.
Category Value
Study start date 2013-02-12

View full details